Blog

Read this newly released study on the Vagus Nerve! Read More

Marie Hilderman1 and Annette Bruchfeld1,2 ABSTRAC: TInflammation and autonomic dysfunction are common find-ings in chronic and end-stage kidney disease and contribute to amarkedly increased risk of mortality in this patient population.The cholinergic anti-inflammatory pathway (CAP) is a vagalneuro-immune circuit that upholds the homoeostatic balanceof inflammatory activity in response to cell injury and patho-gens. CAP models have been

Noninvasive vagus nerve stimulation provided rapid relief of vertigo and headache pain caused by acute vestibular migraine (VM), the most common neurologic cause of vertigo, according to a study using retrospective chart review. The study of 18 patients (Neurology 2019;93[18]: e1715-e1719), conducted at a single tertiary referral center between November 2017 and January 2019, found

Claire-Marie Rangon 1, and Adam Niezgoda 2 1 Child Neurologist and Pain Specialist, INWE’CARE Medical Center, 92210 Saint-Cloud, France 2 Chair and Department of Neurology, University of Medical Sciences, 60-355 Pozna ´n, Poland Abstract: The COVID-19 pandemic seems endless with the regular emergence of new variants. Is the SARS-CoV-2 virus particularly evasive to the immune system, or is it merely

Background: Severe coronavirus disease 2019 (COVID-19) is characterized, in part, by an excessive inflammatory response. Evidence from animal and human studies suggests that vagus nerve stimulation can lead to reduced levels of various biomarkers of inflammation. We conducted a prospective randomized controlled study (SAVIOR-I) to assess the feasibility, efficacy, and safety of non-invasive vagus nerve